Total Payments
$6,445
2024 Payments
$1,412
Companies
36
Transactions
343
Medicare Patients
7,727
Medicare Billing
$496,357
Payment Breakdown by Category
Food & Beverage$6,116 (94.9%)
Education$328.95 (5.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,116 | 339 | 94.9% |
| Education | $328.95 | 4 | 5.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,232 | 65 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $888.46 | 49 | $0 (2024) |
| ABBVIE INC. | $690.89 | 41 | $0 (2024) |
| Janssen Biotech, Inc. | $685.55 | 41 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $581.71 | 24 | $0 (2024) |
| UROVANT SCIENCES INC | $419.98 | 24 | $0 (2022) |
| PFIZER INC. | $398.89 | 23 | $0 (2024) |
| Medtronic, Inc. | $281.34 | 18 | $0 (2023) |
| ConvaTec Inc. | $248.44 | 7 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $116.64 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,412 | 70 | Sumitomo Pharma America, Inc. ($392.10) |
| 2023 | $1,821 | 106 | Sumitomo Pharma America, Inc. ($496.36) |
| 2022 | $1,622 | 88 | UROVANT SCIENCES INC ($333.88) |
| 2021 | $1,590 | 79 | Astellas Pharma US Inc ($642.33) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Medical Urology | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: UROLOGY | ||||||
| 12/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.38 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Oncology | ||||||
| 12/03/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ONCOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: UROLOGY | ||||||
| 11/16/2024 | DENTSPLY IH AB | LOFRIC (Device) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Medical Urology | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: UROLOGY | ||||||
| 11/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $112.54 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: UROLOGY | ||||||
| 09/19/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Pain Management | ||||||
| 09/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: UROLOGY | ||||||
| 09/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.48 | General |
| Category: UROLOGY | ||||||
| 09/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 2,020 | 3,083 | $408,956 | $119,788 |
| 2022 | 9 | 1,970 | 3,147 | $402,750 | $122,632 |
| 2021 | 9 | 1,957 | 3,238 | $469,950 | $138,718 |
| 2020 | 11 | 1,780 | 2,645 | $401,320 | $115,218 |
Total Patients
7,727
Total Services
12,113
Medicare Billing
$496,357
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 566 | 756 | $94,500 | $37,922 | 40.1% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 36 | 261 | $165,735 | $35,235 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 321 | 480 | $96,000 | $34,944 | 36.4% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 792 | 1,209 | $24,180 | $4,689 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 30 | 30 | $6,000 | $2,057 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $7,150 | $2,051 | 28.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 154 | 187 | $9,350 | $1,318 | 14.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 37 | 69 | $5,520 | $1,290 | 23.4% |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | Office | 2023 | 18 | 25 | $161.00 | $149.10 | 92.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 40 | 40 | $360.00 | $132.99 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 555 | 776 | $97,000 | $41,364 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 349 | 509 | $101,800 | $36,025 | 35.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 31 | 236 | $149,860 | $32,470 | 21.7% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 779 | 1,291 | $25,820 | $5,047 | 19.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $9,350 | $3,247 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $5,600 | $2,027 | 36.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 31 | 61 | $4,880 | $1,164 | 23.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 129 | 164 | $8,200 | $1,147 | 14.0% |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | Office | 2022 | 34 | 48 | $240.00 | $142.32 | 59.3% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 42 | 341 | $216,535 | $47,769 | 22.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 431 | 596 | $119,200 | $45,855 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 438 | 639 | $79,975 | $32,265 | 40.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2021 | 756 | 1,258 | $25,160 | $4,993 | 19.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $7,150 | $2,722 | 38.1% |
| 96402 | Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle | Office | 2021 | 42 | 99 | $7,920 | $1,914 | 24.2% |
About Denise Hoffman, PA-C
Denise Hoffman, PA-C is a Physician Assistant healthcare provider based in Kingston, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1821458217.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Denise Hoffman, PA-C has received a total of $6,445 in payments from pharmaceutical and medical device companies, with $1,412 received in 2024. These payments were reported across 343 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,116).
As a Medicare-enrolled provider, Hoffman has provided services to 7,727 Medicare beneficiaries, totaling 12,113 services with total Medicare billing of $496,357. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Kingston, PA
- Active Since 02/29/2016
- Last Updated 07/29/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1821458217
Products in Payments
- GEMTESA (Drug) $1,308
- Nubeqa (Drug) $565.33
- ERLEADA (Drug) $500.93
- MYRBETRIQ (Drug) $390.01
- XTANDI (Drug) $380.70
- BOTOX (Biological) $378.63
- Xtandi (Drug) $335.44
- LUPRON DEPOT (Drug) $312.26
- INTERSTIM (Device) $281.34
- GENTLECATH (Device) $248.44
- Myrbetriq (Drug) $132.13
- Prolaris (Device) $99.23
- LOFRIC (Device) $90.99
- UROLIFT (Device) $73.60
- KEYTRUDA (Biological) $65.71
- iTIND System (Device) $52.90
- PYLARIFY (Drug) $48.40
- BIOFIX (Device) $38.52
- JELMYTO (Drug) $38.17
- Optilume BPH Drug Coated Balloon Catheter (Device) $33.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Kingston
Karl Kruszynski, Pa, PA
Physician Assistant — Payments: $5,602
Physician Assistant $5,602
Kyle Fetterolf, Pa, PA
Physician Assistant — Payments: $2,268
Physician Assistant $2,268
Laura Garofalo, Pa, PA
Physician Assistant — Payments: $2,234
Physician Assistant $2,234
Kurt Schroeder, Pa, PA
Physician Assistant — Payments: $2,077
Physician Assistant $2,077
Colleen Ohene-Agyei, Pa, PA
Physician Assistant — Payments: $1,954
Physician Assistant $1,954
Kathryn Ham, Pa, PA
Physician Assistant — Payments: $1,676
Physician Assistant $1,676